Journal Guide

new antibiotics

This is a Subscribe to Open journal. The below estimate Article Processing Charges (APCs) are $0.00 but additional page charges will apply. More information here.

Antimicrobial Agents and Chemotherapy® features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. The journal also publishes studies involving animal models, pharmacological characterization, and clinical trials.

Antimicrobial Resistance and Infection Control is a global forum for reports encompassing all aspects of resistance development and prevention of health-care associated infections in all health-care settings Antimicrobial Resistance and Infection Control aims to be a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. Infection Control wishes to cover a broad spectrum of 'preeminent practices' and 'best available data' to the 'best interventional and translational research' and innovative (technical) developments in the field of infection control.Antimicrobial Resistance and Infection Control believes that a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, possibilities to prevent transmission and infections and insight into the difference between developed countries and countries with limited resources are key-factors to find future solutions. Antimicrobial Resistance and Infection Control needs to combine best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. Antimicrobial Resistance and Infection Control welcomes all manuscripts related to the filed of HAI prevention and infection control. Some examples are listed below: Prevention of health-care associated infection in hospitals.Infection control and antimicrobial-resistance in high-risk settings (e.g. ICUs).HAI prevention and antimicrobial-resistance in special settings e.g. long-term care facilities.Infection control and antimicrobial-resistance in community settings.Special problems with Infection control and antimicrobial-resistance in resource-limited countries.

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2009 ISI impact factor: 4.32).The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.

BMC Infectious Diseases is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.

Pulsus Group Inc, the medical peer review publisher, publishes the work of medical researchers in a manner that exemplifies the highest standards in research integrity. Main specialty areas include cardiology, gastroenterology, paediatric health, respiratory health, pain, infectious diseases and plastic surgery. Endorsed by Canadian medical societies, Pulsus Group Inc is an ardent supporter of Canadian and international medical research, and publishes journals, supplements and conference reports directed at a broad range of physician specialties. Beyond the print medium, Pulsus Group Inc delivers its content through CD-ROM projects, sponsorship programs and on-line publication.This site has been customized to meet the needs of both health care professionals and non-health care professionals.If you would like to continue, please click the appropriate link below.

Cellular & Molecular Immunology is a bimonthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.The journal publishes Research Articles, Reviews, Minireviews and Brief Reports in all areas of cellular and molecular immunology, including but not limited to: * clinical immunology * comparative immunology * immunobiology * immunogenetics * immunological techniques * immunopathology * immunopharmacology * infection immunology * neuroimmunology * transplantation immunology * tumor immunology * veterinary immunologyAs China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.Manuscripts must provide evidence that can be critically evaluated, and where applicable: * define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.) * deem results 'significant' only using standard statistical methods in biological effects/outcomes studies * use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.

Home to exceptional research and thought-provoking ideas. Open and free, for authors and readers. Chemical Science is the flagship journal of the Royal Society of Chemistry and the home for world-leading, interdisciplinary research from every aspect of the chemical sciences. As a multidisciplinary chemistry journal, our broad scope covers: analytical science and techniques; bioinorganic chemistry; biomaterials; biophysical chemistry; catalysis; chemical biology; chemical engineering; crystal engineering; energy conversion and storage; environmental, sustainable and green chemistry; inorganic chemistry; inorganic materials; main group chemistry; medicinal chemistry; nanoscience; organic chemistry; organic materials; physical chemistry; polymers; porous materials; supramolecular chemistry; and theoretical and computational chemistry.

Chemotherapy publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacological properties of antibacterial, antiviral, and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug resistance, an increasing problem worldwide.

IndiaClen is dedicated to improving the health of the people by promoting clinical practice based on the best evidence of effectiveness and the efficient use of resources. Our goal is to strengthen national health care systems and improve health practices by providing professionals in the field with the tools to analyze the efficacy, efficiency, and equity of interventions and preventive measures. All articles published in our journal are peer reviewed to the highest standard, published online for immediate access.

Clinical Epidemiology and Global Health publishes original research work across all disciplines of medicine and allied sciences, related to clinical epidemiology and global health. Continuing education, evidence updates, students' pre-specified contributions, journal clubs, health-related information of interest to our readers and letters to editors are published.

Clinical Infectious Diseases, one of the most heavily cited journals in the fields of infectious diseases and microbiology, publishes articles on diverse topics in infectious diseases, with a focus on clinical practice. Every issue includes special sections focusing on key topics such as HIV/AIDS, antimicrobial resistance, aging and infectious diseases, and biological weapons. Many articles are published with commentaries by prominent researchers, and current trends and best practices are regularly covered in review articles and practice guidelines. CID also publishes numerous supplements devoted to single topics in the field.

Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a benchmark for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones.Clinical Microbiology Newsletter brings you:– Minireviews on pathogenesis, diagnosis, epidemiology, therapy of infectious diseases– Practical and brief articles on laboratory techniques– Indispensable updates on important clinical problems– Editorials and opinions on controversial issues in laboratory medicine– Helpful tips on improving the laboratory workplace– Instructive case reports that describe or resolve difficult or unusual clinical cases.In these days of cost containment and high expectations, Clinical Microbiology Newsletter can help you streamline procedures and improve results.

Clinical Microbiology Reviews® analyzes the latest developments in clinical microbiology and immunology. Key topics include pathogenic mechanisms, individual and groups of microbial pathogens, clinical and laboratory aspects of newly recognized and reemerging infectious diseases, antimicrobial agents and their applications, and diagnostic laboratory technologies.

Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology.

Based on the concept of "One World, One Health, One Medicine", interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine.Comparative Immunology, Microbiology & Infectious Diseases aims to respond to this concept of "One World, One Health, One Medicine" and to provide a venue for scientific exchange.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals), laboratory animals and animal models of human infections are considered for publication. Papers dealing primarily with epidemiology will only be considered if they demonstrate a clear impact on the pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, immunology or pathogenesis must address issues of comparative medical interest.Review articles are highly appreciated. They should focus either on a pathogen or on analyses of the mechanisms of host-microbe interactions including epidemiological studies.Papers focusing solely on diagnostic techniques, case reports or drug trials will not be published. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).